Liminatus Pharma, Inc.

LIMN·NasdaqCM·Healthcare
Compare
2.7944+0.0044 (+0.16%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close2.7900
Open2.8750
Day range2.66012.9499
52-week range2.4040141.5000
Off day high−5.27%
Off 52-week high−98.03%
Volume33.65K
Avg. volume (3M)214.59K
Market cap3.75M
EPS (TTM)-23.50
Forward P/E—
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.78
Shares outstanding1.34M
Short interest3.66% of float
Earnings date—
Analyst target—
Profit margin0.00%

Against its peers

Compare in full ›
LIMN ATORX.ST PCSA AIM BYSI MDMA.CN
Market cap 3.75M 38.89M 5.41M 6.42M 27.92M 17.63M
P/E (TTM) — — — — — —
Forward P/E — -0.1 -0.5 -0.4 -1.4 —
Price/book 10.4 0.3 -17.0 0.6 -0.8 8.9
Dividend yield — — — — — —
1-year change −95.74% −99.41% −77.18% −90.12% −68.15% +52.00%
Today +0.16% +1.87% −0.26% +0.19% +9.34% −15.79%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All LIMN news ›

From the 4Search news index, newest first.

In the news

1mentions in 30 days
1with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance